EMD SERONO, INC. for EMD SERONO INC
What was lobbied
12 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 3: Elijah E. Cummings Lower Drug Costs Now Act; all provisions of the bill H.R. 19: Lower Costs, More Cures Act of 2021; all provisions of the bill H.R. 1957: Veterans Infertility Treatment Act of 2021; all provisions of the bill H.R. 4390: Preserving Rules Ordered for The Entities Covered Through (PROTECT) 340B Act of 2021; all provisions of the bill H.R. 5030: Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act; all provisions of the bill H.R. 5376: Build Back Better Act; all provisions of the bill H.R. 6000: Cures 2.0 Act; all healthcare provisions of the bill H.R. 6584: Diverse and Equitable Participation in Clinical Trials (DEPICT) Act; all provisions of the bill H.R. 6963: Accelerated Approval Integrity Act of 2022; all provisions of the bill H.R. 6996: Accelerating Access for Patients Act of 2022; all provisions of the bill H.R. 7667: Food and Drug Amendments of 2022; provisions related to drug development user fees S. 2210: Better Care Better Jobs Act; all provisions of the bill S. 2706: Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act; all provisions of the bill S. 4348: Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022; provisions related to drug development user fees 2021 Notice of Benefit and Payment Parameters Proposed Rule - 340B Drug Pricing Program policy issues General discussions regarding support for, and importance of, care-giving General healthcare issues surrounding the COVID-19 pandemic General issues surrounding healthcare supply chain General discussions regarding drug cost and pricing policy issues General discussions regarding The American Jobs Plan General discussions related to the Cancer Moonshot Initiative and the Advanced Research Projects Agency for Health (ARPA-H) General discussion related to the Prescription Drug User Fee Act Reauthorization
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BORCK New | Senate Budget Committee (Chairman Mike Enzi) - Policy Director (5/18 - 11/19) Professional Staff Member (7/15 - 5/18); Representative Todd Rokita - Deputy Chief of Staff & Legislative Director (4/13 - 7/15) Legislative Assistant (10/11 - 4/13) |
| MALLORI ANNE MERANDINO | — |
| TERRI STEWART | — |
Medicare/Medicaid MMM
H.R. 3: Elijah E. Cummings Lower Drug Costs Now Act; all provisions of the bill H.R. 5376 - Build Back Better Act; all provisions of the bill 2021 Notice of Benefit and Payment Parameters Proposed Rule - 340B Drug Pricing Program policy issues General healthcare issues surrounding the COVID-19 pandemic
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BORCK New | Senate Budget Committee (Chairman Mike Enzi) - Policy Director (5/18 - 11/19) Professional Staff Member (7/15 - 5/18); Representative Todd Rokita - Deputy Chief of Staff & Legislative Director (4/13 - 7/15) Legislative Assistant (10/11 - 4/13) |
| MALLORI ANNE MERANDINO | — |
| TERRI STEWART | — |
Pharmacy PHA
H.R. 3: Elijah E. Cummings Lower Drug Costs Now Act; all provisions of the bill H.R. 4390: Preserving Rules Ordered for The Entities Covered Through (PROTECT) 340B Act of 2021; all provisions of the bill H.R. 5376: Build Back Better Act; all provisions of the bill 2021 Notice of Benefit and Payment Parameters Proposed Rule - 340B Drug Pricing Program policy issues General healthcare issues surrounding the COVID-19 pandemic General issues surrounding healthcare supply chain General issues related to pharmaceutical pricing General issues related to drug development lifecycle
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BORCK New | Senate Budget Committee (Chairman Mike Enzi) - Policy Director (5/18 - 11/19) Professional Staff Member (7/15 - 5/18); Representative Todd Rokita - Deputy Chief of Staff & Legislative Director (4/13 - 7/15) Legislative Assistant (10/11 - 4/13) |
| MALLORI ANNE MERANDINO | — |
| TERRI STEWART | — |
Budget/Appropriations BUD
General discussion related to President Biden's FY 2022 Proposed Budget
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BORCK New | Senate Budget Committee (Chairman Mike Enzi) - Policy Director (5/18 - 11/19) Professional Staff Member (7/15 - 5/18); Representative Todd Rokita - Deputy Chief of Staff & Legislative Director (4/13 - 7/15) Legislative Assistant (10/11 - 4/13) |
| MALLORI ANNE MERANDINO | — |
| TERRI STEWART | — |
Taxation/Internal Revenue Code TAX
General discussions related to the Budget Reconciliation bills and Section 163(n) issues related to inbound taxation (Global Intangible Low-Taxed Income (GILTI); Foreign-derived Intangible Income (FDII); Base-Erosion and Anti-Abuse Tax (BEAT), and the Stopping Harmful Inversions and Ending Low-Tax Developments (SHIELD) Rule)
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
| PAUL JEFFREY TREADGOLD | — |
Science/Technology SCI
H.R. 4521: United States Innovation and Competition Act of 2021; provisions related to the inclusion of the CHIPS Act & FABS Act and issues related to the outbound investment review mechanism (National Critical Capabilities Act) S. 1260: United States Innovation and Competition Act of 2021 (USICA): provisions related to the inclusion of the CHIPS Act & FABS Act and issues related to the outbound investment review mechanism (National Critical Capabilities Act) Bipartisan Innovation Act; provisions related to the inclusion of the CHIPS Act & FABS Act and issues related to the outbound investment review mechanism (National Critical Capabilities Act)
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
| PAUL JEFFREY TREADGOLD | — |
Economics/Economic Development ECN
General discussion of issues related to caregiving and the Healthy Women, Healthy Economies initiative
| Lobbyist | Covered position, as disclosed |
|---|---|
| MALLORI ANNE MERANDINO | — |
Family issues/Abortion/Adoption FAM
H.R.1957: Veterans Infertility Treatment Act of 2021; all provisions of the bill
| Lobbyist | Covered position, as disclosed |
|---|---|
| MALLORI ANNE MERANDINO | — |
Veterans VET
H.R. 8238: Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2023; provisions related to funding infertility services at Veterans Affairs General discussions related to infertility treatment of the Veteran community
| Lobbyist | Covered position, as disclosed |
|---|---|
| MALLORI ANNE MERANDINO | — |
Copyright/Patent/Trademark CPT
General issues related to domestic and global intellectual property protections
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BORCK New | Senate Budget Committee (Chairman Mike Enzi) - Policy Director (5/18 - 11/19) Professional Staff Member (7/15 - 5/18); Representative Todd Rokita - Deputy Chief of Staff & Legislative Director (4/13 - 7/15) Legislative Assistant (10/11 - 4/13) |
| MALLORI ANNE MERANDINO | — |
| TERRI STEWART | — |
Trade (domestic/foreign) TRD
General discussions related to Section 301 tariffs and support for tariff exclusion process
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
| PAUL JEFFREY TREADGOLD | — |
Chemicals/Chemical Industry CHM
General discussions related to the Toxic Substance Control Act (TSCA) Implementation Review Process of the New and Existing Chemicals programs
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
| PAUL JEFFREY TREADGOLD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.